15.3.2018

Central Bank of Savings Banks Finland – Update of EMTN Programme and Issue of EUR 300 Million Notes

Related services

Capital Markets & Public M&A

We advised the Central Bank of Savings Banks Finland Plc in the update of a EUR 2,000,000,000 Euro Medium Term Note Programme (EMTN). Under the EMTN Programme, the Central Bank of Savings Banks Finland Plc may issue medium term notes that may be listed on the Irish Stock Exchange.

The Central Bank of Savings Banks Finland Plc issued senior unsecured floating rate notes in March 2018 in the aggregate principal amount of EUR 300 million due 8 March 2021. The issuance was documented under the EMTN Programme and listed on the Irish Stock Exchange.

The Central Bank of Savings Banks Finland Plc is a part of the Savings Banks Group and the Savings Banks Amalgamation. The role of the Central Bank of Savings Banks Finland Plc is to operate as the central credit institution of the Savings Banks Group.

Latest references

Suominen Corporation – Rights Issue

We advised Suominen Corporation in connection with its rights issue. The offering was oversubscribed, and the company raised gross proceeds of approximately EUR 28 million. We also advised Suominen in connection with the renegotiation of the terms of the company’s three-year EUR 100 million syndicated credit facility, under which the maturity was extended and headroom was added to the financial covenants. “I would like to thank our shareholders for their support and confidence in Suominen’s future. The completion of the Offering will enable us to accelerate the implementation of our Full Potential Program while strengthening our capital structure. Our transformation particularly focuses on enhancing the reliability and efficiency of our production and supply, and on reinforcing our commercial capabilities, allowing us to better meet the expectations of our customers and shareholders”, comments Charles Héaulmé, President and CEO of Suominen. Suominen is a nonwovens manufacturer operating in global markets. Suominen creates value by taking fiber raw materials and turning them into nonwovens that the company’s customers convert into both consumer and professional end products. Suominen’s vision is to be the frontrunner for nonwovens innovation and sustainability. Suominen’s net sales in 2025 were EUR 412.4 million and the company has almost 700 professionals working in Europe and in the Americas. Suominen’s shares are listed on Nasdaq Helsinki.

Finnish Cultural Foundation – EUR 76 million secondary share sale in an accelerated book-building

We advised Finnish Cultural Foundation and Nordea, who acted as the Sole Bookrunner, in the sale of 3 million shares in Huhtamäki Oyj held by Finnish Cultural Foundation in an accelerated book-building. The shares represented approximately 2.8% of all shares in Huhtamäki Oyj. The aggregate selling price of the shares amounted to approximately EUR 76 million.

Huhtamäki – EUR 300 million bond and tender offer of bond maturing in 2027

We advised Huhtamäki Oyj on its issuance of a EUR 300 million 6-year senior unsecured bond under the EMTN programme and on the tender offer of its EUR 500 million senior unsecured bond maturing in 2027. The new bond bears interest at a fixed rate of 3.875 per cent per annum. Huhtamäki used the net proceeds from the issuance of the new bond for the partial repurchase of its bond maturing in 2027 and for general corporate purposes.

Taaleri – Acquisition of a majority stake in Nordic Science Investments

We are acting as legal adviser to Taaleri Plc on its acquisition of a 51 per cent ownership stake in Nordic Science Investments Oy (NSI), marking Taaleri’s expansion into deeptech-driven venture capital. Through the transaction, Taaleri broadens its private equity offering into early-stage venture capital funds as well as the commercialisation and scaling of research-driven innovations. NSI is a Finnish venture capital fund manager operating across the Nordic and Baltic regions, focusing on early-stage investments in research- and science-based technologies. Its portfolio companies develop, among other things, health technologies, life sciences, advanced materials and AI-driven solutions. In addition to providing growth capital, NSI supports spin-out companies with strategic guidance, access to networks and assistance in building teams during the early phases of business development. NSI’s first fund, the EUR 45 million NSI Nordic Science I Ky, was established in 2024 and has to date invested in 22 early-stage companies in Finland, Sweden and the Baltic countries. Taaleri is a specialist in investments, private asset management and non-life insurance, with a strong position in renewable energy, bioindustry and housing investments as well as credit risk insurance. Taaleri has EUR 2.7 billion of assets under management in its private equity funds, co-investments and single-asset vehicles, employs approximately 130 people and is listed on Nasdaq Helsinki. The founders of NSI will continue in their operational roles following the transaction. The completion of the transaction is subject to approval by the FIN-FSA.

Search from the site.